Publication

Detection of mutations in homologous recombination repair (HRR) genes in tumour tissue (TT) and circulating tumour DNA (ctDNA) from patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) in the phase III PROpel trial

Armstrong, A. J.
; 
Saad, F.
; 
Thiery-Vuillemin, A.
; 
Oya, M.
; 
Shore, N. D.
; 
Mehra, N.
; 
Ozguroglu, M.
; 
Gedye, C.
; 
Sartor, O.
; 
Poehlein, C. H.
... show 8 more
Citations
Altmetric:
Abstract
Authors
Armstrong, A. J.
Saad, F.
Thiery-Vuillemin, A.
Oya, M.
Shore, N. D.
Mehra, N.
Ozguroglu, M.
Gedye, C.
Sartor, O.
Poehlein, C. H.
Qiu, P.
Liu, Y. Z.
Riva, L.
Harrington, L.
Barker, L.
Del Rosario, P. M. D.
Barnicle, A.
Clarke, Noel W
Affiliation
Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC
Description
Date
2022
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Armstrong AJ, Saad F, Thiery-Vuillemin A, Oya M, Shore ND, Mehra N, et al. Detection of mutations in homologous recombination repair (HRR) genes in tumour tissue (TT) and circulating tumour DNA (ctDNA) from patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) in the phase III PROpel trial. Annals of Oncology. 2022 Sep;33(7):S1168-S. PubMed PMID: WOS:000866211601627.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/625976
Embedded videos